AstraZeneca PLC
31 March 2008
Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rules DR 3.1.4R
We hereby inform you that on 28 March 2008 the following Directors of
AstraZeneca PLC were each granted an award under the terms of the AstraZeneca
Performance Share Plan over the Company's USD0.25 Ordinary Shares.
Target Award Total interest Percentage
number price Normal in shares of shares
of shares per vesting after this in issue
Name of Director awarded share date award
D R Brennan 161,546 1882p 28 March 2011 See below See below
S Lowth 58,448 1882p 28 March 2011 76,192 0.005%
J S Patterson 57,385 1882p 28 March 2011 197,107 0.014%
The AstraZeneca Performance Share Plan was approved by shareholders at the
Company's AGM in 2005. Awards made under the Plan may not generally vest before
the third anniversary of the relevant date of grant nor unless the specified
performance target(s) have been met at the end of the three year period which,
for this award, is 1 January 2008 to 31 December 2010.
The performance target that applies to this award is the Company's Total
Shareholder Return ('TSR') compared to the TSR of a selected peer group of 12
other pharmaceutical companies. The actual number of shares to which a
participant may become unconditionally entitled will depend on the extent to
which the performance target(s) have been met. A summary of the Plan, including
a more detailed explanation of the performance target(s), can be found in the
AstraZeneca Annual Report and Form 20-F Information 2007 which is available on
the Company's website www.astrazeneca.com.
Mr Brennan has interests in the Company's Ordinary Shares and American
Depositary Shares (ADSs). One ADS equals one Ordinary Share. In total, Mr
Brennan now has an interest in 395,974 Ordinary Shares and 111,273 ADSs, which
together represent approximately 0.035% of the number of shares currently in
issue.
G H R Musker
Company Secretary
31 March 2008
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.